Mutlu Arat

6.6k total citations
128 papers, 1.7k citations indexed

About

Mutlu Arat is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mutlu Arat has authored 128 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Hematology, 33 papers in Oncology and 26 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mutlu Arat's work include Hematopoietic Stem Cell Transplantation (65 papers), Acute Lymphoblastic Leukemia research (23 papers) and Acute Myeloid Leukemia Research (16 papers). Mutlu Arat is often cited by papers focused on Hematopoietic Stem Cell Transplantation (65 papers), Acute Lymphoblastic Leukemia research (23 papers) and Acute Myeloid Leukemia Research (16 papers). Mutlu Arat collaborates with scholars based in Türkiye, France and Italy. Mutlu Arat's co-authors include Osman İlhan, Hamdi Akan, Muhıt Özcan, Önder Arslan, Günhan Gürman, Harika Çelebi, Klara Dalva, Meral Beksaç, Jakob Passweg and Celalettin Üstün and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Mutlu Arat

116 papers receiving 1.7k citations

Peers

Countries citing papers authored by Mutlu Arat

Since Specialization

Citations

This map shows the geographic impact of Mutlu Arat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mutlu Arat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mutlu Arat more than expected).

Fields of papers citing papers by Mutlu Arat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mutlu Arat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mutlu Arat. The network helps show where Mutlu Arat may publish in the future.

Co-authorship network of co-authors of Mutlu Arat

This figure shows the co-authorship network connecting the top 25 collaborators of Mutlu Arat. A scholar is included among the top collaborators of Mutlu Arat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mutlu Arat. Mutlu Arat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ptcy Overcomes HLA Mismatch in Unrelated Donor Transplant for Acute Lymphoblastic Leukemia: A Study from the ALWP of the EBMT 2024 ·Blood ·Jaime Sanz, (unknown), Alexander Kulagin, Nicolaus Kröger, Montserrat Rovira, (unknown), Mutlu Arat, Juan Montoro, Jurjen Versluis, Péter Reményi, Simona Sica, Didier Blaise, Muhammad Wasif Saif, Jan Vydra, Franca Fagioli, Erfan Nur, Sebastian Giebel, Simona Piemontese, (unknown), (unknown)	0
2	Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience 2023 ·Blood ·(unknown), Uğur Şahin, Güldane Cengiz Seval, Deniz Şahin, (unknown), Sinem Civriz Bozdağ, Selami Koçak Toprak, (unknown), Meltem Kurt Yüksel, Önder Arslan, Taner Demirer, Günhan Gürman, Osman İlhan, Meral Beksaç, Muhıt Özcan, Mutlu Arat	1
3	Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study 2023 ·Future Oncology ·Mutlu Arat, (unknown), (unknown), Yahya Büyükaşık, Seçkin Çağırgan, Birol Güvenç, Emın Kaya, (unknown), Ozan Salim, Filiz Vural, (unknown), Meltem Kurt Yüksel, (unknown), (unknown), (unknown), Osman İlhan	0
4	Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT) 2022 ·Bone Marrow Transplantation ·Enrico Maffini, Myriam Labopin, Dietrich W. Beelen, Nicolaus Kroeger, Mutlu Arat, Keith Wilson, Jacques‐Olivier Bay, Arnold Ganser, Hans Martin, Jakob Passweg, Panagiotis Kottaridis, Ibrahim Yakoub‐Agha, Rocío Parody Porras, Eva Wagner, Jordi Esteve, Francesco Lanza, Arnon Nagler, Mohamad Mohty	11
5	Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT 2022 ·Bone Marrow Transplantation ·(unknown), Myriam Labopin, Sebastian Giebel, Thomas Schroeder, Nicolaus Kröger, Mutlu Arat, Bipin N. Savani, Alexandros Spyridonidis, Rose‐Marie Hamladji, Victoria Potter, Ana Berceanu, Ibrahim Yakoub‐Agha, Alessandro Rambaldi, Hakan Özdoğu, Jaime Sanz, (unknown), Mohamad Mohty	1
6	Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT 2022 ·Bone Marrow Transplantation ·Ivetta Danylesko, Christophe Peczynski, Myriam Labopin, Emmanuelle Polge, Johanna Tischer, Didier Blaise, Yener Koç, Zafer Gülbaş, Fabio Ciceri, Mutlu Arat, Luca Castagna, Benedetto Bruno, Anna Maria Raiola, (unknown), Bipin N. Savani, Simona Piemontese, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty	2
7	Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT 2021 ·Bone Marrow Transplantation ·Annalisa Ruggeri, Myriam Labopin, Emanuele Angelucci, Didier Blaise, Fabio Ciceri, Yener Koç, Patrizia Chiusolo, (unknown), Zafer Gülbaş, Luca Castagna, Benedetto Bruno, Mutlu Arat, Massimo Martino, Arnon Nagler, Mohamad Mohty	6
8	Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT 2021 ·Journal of Hematology & Oncology ·Jaime Sanz, Jacques‐Emmanuel Galimard, Myriam Labopin, Boris V. Afanasyev, (unknown), Emanuele Angelucci, Nicolaus Kröger, Yener Koç, Fabio Ciceri, José L. Díez‐Martín, Mutlu Arat, Simona Sica, Montserrat Rovira, Mahmoud Aljurf, Johanna Tischer, Bipin N. Savani, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty	19
9	The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies 2019 ·Bone Marrow Transplantation ·(unknown), Jakob Passweg, Helen Baldomero, Grzegorz Basak, Christian Chabannon, Selim Corbacioglu, Rafael F. Duarte, Jürgen Kuball, Arjan C. Lankester, Silvia Montoto, Régis Peffault de Latour, John A. Snowden, Jan Styczyński, Ibrahim Yakoub‐Agha, Mutlu Arat, Mohamad Mohty, Nicolaus Kröger	114
10	Vanishing bile duct syndrome after allogeneic bone marrow transplantation: Is it the end of the road? 2013 ·The Turkish Journal of Gastroenterology ·Şule Mine Bakanay, (unknown), Mehmet Bektaş, Ramazan Idılman, Esra Erden, Mutlu Arat, Önder Arslan	1
11	Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation 2008 ·Haematologica ·André Tichelli, Jakob Passweg, Dorota Wójcik, Alicia Rovó, J. L. Harousseau, Tamás Masszi, A. R. Zander, A N Békássy, (unknown), Mutlu Arat, Simona Sica, P Lutz, Gèrard Socié, (unknown)	111
12	Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra 2007 ·Transfusion and Apheresis Science ·Ender Soydan, (unknown), Klara Dalva, Pervin Topçuoğlu, (unknown), Önder Arslan, Osman İlhan, Mutlu Arat	8
13	Fatal fulminant hepatic failure during treatment of multiple myeloma 2005 ·Ankara Üniversitesi Tıp Fakültesi Mecmuası ·Sibel Ertek, Mutlu Arat, İrfan Soykan, Ramazan Idılman, Cemil Ekinci, Meral Beksaç	1
14	Imatinib only for molecular relapse is not sufficient to achieve a durable complete chimeric status and molecular remission after allo HCT in CML 2005 ·Biology of Blood and Marrow Transplantation ·Ender Soydan, (unknown), Meral Beksaç, Hakan Koç, Günhan Gürman, Osman İlhan, Mutlu Arat	0
15	Ursodeoxycholic acid treatment in isolated chronic graft‐vs.‐host disease of the liver 2005 ·Clinical Transplantation ·Mutlu Arat, Ramazan Idılman, Ender Soydan, İrfan Soykan, Esra Erden, Selim Karayalçın, Hamdi Akan	7
16	Lamivudine prophylaxis for prevention of chemotherapy‐induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies 2004 ·Journal of Viral Hepatitis ·Ramazan Idılman, Mutlu Arat, Ender Soydan, Murat Törüner, (unknown), Hakan Akbulut, Önder Arslan, Muhıt Özcan, A.R. Türkyilmaz, Mithat Bozdayı, Selim Karayalçın, D H Van Thiel, A. Özden, Meral Beksaç, Hamdi Akan	72
17	High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation 2003 ·Bone Marrow Transplantation ·Taner Demirer, (unknown), Meltem Aylı, Yavuz Selim Genç, Osman İlhan, Hakan Koç, (unknown), Mutlu Arat, Nazan Günel, (unknown), Sibel Dinçer, (unknown), (unknown), (unknown), E. Seyrek, Gülsüm Özet, (unknown), (unknown)	5
18	Allogeneic Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia 2001 ·Therapeutic Apheresis ·Günhan Gürman, Harika Çelebi, Celalettin Üstün, Mutlu Arat, Osman İlhan, Muhıt Özcan, Önder Arslan, A. Uysal, Hamdi Akan, Meral Beksaç, Nahıde Konuk, Hakan Koç	5
19	Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of İbni Sina Hospital 2000 ·Bone Marrow Transplantation ·Önder Arslan, (unknown), Mutlu Arat, Harika Çelebi, Muhıt Özcan, Günhan Gürman, Celalettin Üstün, Taner Demirer, Hamdi Akan, Osman İlhan, Nahıde Konuk, Meral Beksaç, A. Uysal, Hakan Koç	2
20	Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft verses host disease 1999 ·Pathology & Oncology Research ·Celalettin Üstün, Muhıt Özcan, Günhan Gürman, Mehtap Çakır, Selim Erekul, Gülen Akyol, Mutlu Arat, Harika Çelebi, (unknown), Osman İlhan, Taner Demirer, Meral Beksaç, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact